• FDA: Don’t use Zicam, that homeopathic stuff with Zinc you put in your nose for colds, etc. You can permanently lose your smell! Since 1999, the FDA has received more than 130 reports of consumers losing their sense of smell, or anosmia. Yikes! [CNN]

• These guys always delay action dates – FDA needs more time for GSK and Genmab’s Arzerra (ofatumumab). [Reuters UK]

• GSK on Facebook and MySpace? [iHealthBeat]

• Isolagen files for bankruptcy, enters Graveyard. [BizJournals]

• Covidien pays Nuvo Research $10M upfront for pain meds. [Yahoo!Finance]

• CeNeRx BioPharma raises $9M for its CNS drugs. [LocalTechWire]

• Looks to us like Amgen is betting the house on Denosumab…hmmm. [Bloomberg]

• Germany pissed at Pfizer for hiding data. [BusinessWire]

• Genentech must stop work on three drug development projects under terms of a contract with Biogen. [WSJ]

• Finally, by the time you read this, Cell Therapeutics’ amended debt tender offer will have expired at 5PM EST. What’s next for the struggling drug developer??? [The Street]

Anonymous Tip? Comments? Contact us: hr AT iguanabio DOT com

Related Posts